Acta Scientific Nutritional Health (ASNH)(ISSN: 2582-1423)

Review Article Volume 5 Issue 7

Nutraceuticals: Frontier in Healthcare

Firoj A Tamboli1*, Harinath N More1, Vishal H Thorat1, Asha S Jadhav1 and Niolfar A Tamboli2

1Department of Pharmacognosy, Bharati Vidyapeeth College of Pharmacy, Maharashtra, India
2Hon. Shri. Annasaheb Dange Ayurved Medical College, Post Graduate and Research Center, Maharashtra, India

*Corresponding Author: Firoj A Tamboli, Head, Department of Pharmacognosy, Bharati Vidyapeeth College of Pharmacy, Maharashtra, India.

Received: April 09, 2021; Published: June 07, 2021

Abstract

  Nutraceutical is a term used for segregated products from processed foods, supplements, specialty foods and food products that are used as nutrients in balanced foods. The lifestyles of people around the world have changed over the past century due to increased incomes, declining exercise and preferences for unhealthy foods. Nutraceuticals are very popular because of their safety, nutritional value and treatment. They are used in the treatment and prevention of various diseases, including heart disease, cancer, diabetes, Alzheimer’s disease, stroke and Parkinson’s disease, as well as obesity. Better understanding “from treatment to prevention” leads to an increase in the demand for nutraceutical. Nutraceutical has lead to in a new era of medicine and health, which has made the food and pharmaceutical industry a business of research interest.

Keywords:Nutraceutical; Balanced Foods; Parkinson’s Disease; Obesity; Antioxidants

References

  1. De Felice SL. “The nutraceutical revolution, its impact on food industry”. Trends in Food Science and Technology 2 (1995): 59-61.
  2. Mannion M. “Nutraceutical revolution continues at Foundation for Innovation in Medicine Conference”. American Journal of Natural Medicines 5 (1998): 30-33.
  3. Andlauer W and Furst P. “Nutraceuticals: a piece of history, present status and outlook”. Food Research International 35 (2002): 171-176.
  4. Ruchi S., et al. “Role of Nutraceuticals in health care: A review”. International Journal of Green Pharmacy 11 (2017): 386-394.
  5. Whitman M. “Understanding the perceived need for complementary and alternative nutraceuticals: lifestyle issues”. Clinical Journal of Oncology Nursing 5 (2001): 190-194.
  6. Childs NM. “Nutraceutical industry trends”. Nutraceuticals: Nutritionally Functional Foods 1 (1999): 73-85.
  7. Golla U. “Emergence of nutraceuticals as the alternative medications for pharmaceuticals”. International Journal of Complementary and Alternative Medicine 3 (2018): 155-158.
  8. Brower B. “Nutraceuticals: Poised for a healthy slice of the market”. Nature Biotechnology8 (1998): 728-731.
  9. https://www.bccresearch.com/market-research/food-and-beverage/nutraceuticals-markets-report-fod013f.html
  10. De Felice SL. “Nutraceuticals: Opportunities in an Emerging Market”. Script Magazine (1992).
  11. Dureja H. “Developments in nutraceuticals”. Indian Journal of Pharmacology 35 (2003): 363-372.
  12. Mobarhan S., et al. “Micronutrient supplementation trials and the reduction of cancer and cerebrovascular incidences and mortality”. Nutrition Review 52 (1994): 102-105.
  13. Jong WP. Anesthesia and Analgesia 97 (2003): 748.
  14. Braeckman J. “The Extract of Serenoa repens in the treatment of benign prostatic hyperplasia: a multicenter open study”. Current Therapeutic Research 55 (1994): 776-785.
  15. Craig W and Beck L. “Phytochemicals: Health Protective Effects”. Canadian Journal of Dietetic Practice and Research 60 (1999): 78-84.
  16. Klein C., et al. “From food to nutritional support to specific nutraceuticals: a journey across time in the treatment of disease”. Journal of Gastroenterology 35 (2000): 1-6.
  17. Pandey M., et al. “Nutraceuticals: New era of medicine and health”. Asian Journal of Pharmaceutical and Clinical Research 3-1 (2010): 11-15.
  18. Garima Verma., et al. International Journal of Pharmacy and Therapeutics 7-4 (2016): 152-160.
  19. Thomasset SC., et al. “Dietary polyphenolic Phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties”. International Journal of Cancer 120 (2007): 451-458.
  20. Frydoonfar HR., et al. “The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin”. Colorectal Disease 5 (2003): 149-152.
  21. Limer JL and Speirs V. “Phyto-oestrogens and breast cancer chemoprevention”. Breast Cancer Research 6 (2004): 119-127.
  22. Mandel S., et al. “Proceedings from the Third Int. Conf. Mechanism of Action of Nutraceuticals”. Journal of Nutritional Biochemistry 16 (2005): 513-520.
  23. Kucuk O., et al. “Lycopene in the Treatment of Prostate Cancer”. Pure and Applied Chemistry 74 (2002): 1443-1450.
  24. Ferrucci V., et al. “Natural compounds for pediatric cancer treatment”. Naunyn-Schmiedeberg's Archives of Pharmacology 389 (2016): 131-149.
  25. Caterson ID and Gill TP. “Obesity: epidemiology and possible prevention”. Best Practice and Research: Clinical Endocrinology and Metabolism 4 (2002): 595-610.
  26. Si-quan L and Zhang Q H. “Advances in the development of functional foods from buckwheat”. Critical Review in Food Science and Nutrition 41 (2001): 451-464.
  27. Bell SJ and Good rick G K. “A Functional Food Product for the Management of Weight”. Critical Review in Food Science and Nutrition 42 (2002): 163-178.
  28. Woodgate DE and Conquer JA. “Prevalence of self-treatment with complementary products and therapies for weight loss: A randomized, cross-sectional Study in Overweight Obese Patients in Colombia”. Current Therapeutic Research 64 (2003): 248-262.
  29. Martinez SE., et al. “ Pharmacological effects of a C-phycocyanin-based multicomponent nutraceutical in an in-vitro canine chondrocyte model of osteoarthritis”. Canadian Journal of Veterinary Research 79 (2015): 241-249.
  30. Bottegoni C., et al. “Oral chondroprotection with nutraceuticals made of chondroitin sulphate plus glucosamine sulphate in osteoarthritis”. Carbohydrate Polymer 109 (2014): 126-138.
  31. Kalioraa A C., et al. “Dietary antioxidants in preventing atherogenesis”. Atherosclerosis 187 (2006): 1-17.
  32. Notarnicola A., et al. “Methylsulfonylmethane and boswellic acids versus glucosamine sulfate in the treatment of knee arthritis: Randomized trial”. International Journal of Immunopathology and Pharmacology 29 (2015): 140-146.
  33. Kim HP., et al. “Effects of naturally occurring flavonoids and bioflavonoids on epidermal cycloxygenase and lipoxygenase from guinea pigs”. Prostaglandins, Leukotrienes and Essential Fatty Acids 58 (1998): 17-24.
  34. Jachak SM. “Natural products: Potential source of COX inhibitors”. CRIPS1 (2001): 12-15.
  35. Srivastava Shubhra. “Nutraceuticals: A Review”. Journal of Chronotherapy and Drug Delivery1 (2015): 1-10.
  36. Formica J V and Regelson W. “Review of the Biology of Quercetin and Related Bioflavonoids”. Food and Chemical Toxicology 33 (1995): 1061-1080.
  37. VranesiA Bender D. “The role of nutraceuticals in anti-aging medicine”. Acta Clinica Croatica 49 (2010): 537-544.
  38. Katta R and Brown DN. “Diet and Skin Cancer: The Potential Role of Dietary Antioxidants”. Journal of Skin Cancer 7 (2015): 1-10.
  39. Shan B., et al. “Antioxidant capacity of Tewnty Six spice extracts and characterization of their phenolic constituents”. Journal of Agricultural and Food Chemistry 53 (2005): 7749-7759.
  40. Glenville M. “Nutritional supplements in pregnancy: commercial push or evidence based”. Current Opinion in Obstetrics and Gynecology 18 (2006): 642-647.
  41. Nunomura A., et al. “Oxidative Damage is the Earliest Event in Alzheimer Disease”. Journal of Neuropathology and Experimental Neurology 60 (2001): 759-767.
  42. Dohrmann DD., et al. “Japanese, Mediterranean and Argentinean Diets and Their Potential Roles in Neurodegenerative Diseases”. Food Research International 120 (2019): 464-477.
  43. Brower V. “A nutraceutical a day may keep the doctor away”. EMBO Reports8 (2005) 708-711.
  44. Tatton, W. et al. “Apoptosis in Parkinson's disease: Signals for neuronal degradation”. Annals of Neurology3 (2003): S61-S70.
  45. Ramaa CS., et al. “Nutraceuticals- An emerging era in the treatment and prevention of cardiovascular diseases”. Current Pharmaceutical Biotechnology 7 (2006): 15-23.
  46. Chauhan B., et al. “Current Concepts and prospects of herbal Nutraceuticals: A Review”. Journal of Advanced Pharmaceutical Technology and Research 4 (2013): 4-8.

Citation

Citation: Firoj A Tamboli.,et al. “Nutraceuticals: Frontier in Healthcare".Acta Scientific Nutritional Health 5.7 (2021): 22-26.

Copyright

Copyright: © 2021 Firoj A Tamboli., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days
Impact Factor1.034

Indexed In





News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US